Taha Al-Shaikhly
Overview
Explore the profile of Taha Al-Shaikhly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matheny M, Ghaffari G, Al-Shaikhly T
J Allergy Clin Immunol Pract
. 2025 Jan;
PMID: 39756512
No abstract available.
2.
Matheny M, Craig T, Al-Shaikhly T
Allergy Asthma Proc
. 2024 Dec;
46(1):11-18.
PMID: 39741373
Patients with mast cell activation syndrome (MCAS) can be refractory to standard antimediator therapy. Alternative treatment options to reduce disease burden and improve quality of life are needed. To compile...
3.
Deng E, Craig T, Nguyen D, Al-Shaikhly T
Allergy Asthma Proc
. 2024 Nov;
45(6):e93-e100.
PMID: 39517080
Sulfonamides are associated with severe cutaneous adverse reactions (SCARs). Coronavirus disease 2019 (COVID-19) triggers an immune response, which may increase the likelihood of developing a hypersensitivity reaction. We sought to...
4.
Al-Shaikhly T, Cox A, Nowak-Wegrzyn A, Cianferoni A, Katelaris C, Ebo D, et al.
J Allergy Clin Immunol Pract
. 2024 Nov;
12(12):3242-3249.e1.
PMID: 39488768
Background: Pollen-food allergy syndrome (PFAS) is common among patients with allergic rhinitis. Treatment recommendations for patients with PFAS remain variable. Objective: To develop consensus recommendation statements for managing patients with...
5.
Haber C, Al-Shaikhly T, Jhaveri P
J Allergy Clin Immunol Pract
. 2024 Aug;
12(11):3150-3152.e1.
PMID: 39151688
No abstract available.
6.
Al-Shaikhly T, Al-Obaydi S, Craig T, Henao M
Transpl Infect Dis
. 2024 Aug;
26(5):e14355.
PMID: 39136148
Background: While a penicillin allergy label has been linked to various negative clinical outcomes, limited studies have specifically characterized the implication of sulfonamide allergy labels (SAL) on clinical outcomes. We...
7.
Dluzynski D, Al-Shaikhly T, Paules C, Henao M
J Allergy Clin Immunol Glob
. 2024 Jul;
3(3):100293.
PMID: 39071730
Background: Tixagevimab-cilgavimab is a combination of 2 mAbs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In December 2021, the Food and Drug Administration issued Emergency Use Authorization for intramuscular...
8.
Stone S, Henao M, Craig T, Al-Shaikhly T
Pulm Ther
. 2024 May;
10(2):225-236.
PMID: 38782820
Introduction: The presence of antibiotic allergy labels can have harmful impacts on clinical outcomes, particularly among immunosuppressed patients, in whom there have been associations with increased complications, readmission rates, and...
9.
Al-Shaikhly T, Norris M, Dennis E, Liu G, Craig T
J Allergy Clin Immunol Pract
. 2024 Feb;
12(6):1558-1567.
PMID: 38423294
Background: Biologic modifiers targeting type 2 (T2) airway inflammation are effective in reducing asthma exacerbation. However, real-world and comparative effectiveness studies remain limited. Objective: To examine and compare the real-world...
10.
Zybaczynska J, Norris M, Modi S, Brennan J, Jhaveri P, Craig T, et al.
J Allergy Clin Immunol Pract
. 2023 Oct;
12(1):106-110.
PMID: 37832818
Background: Review articles play a critical role in informing medical decisions and identifying avenues for future research. With the introduction of artificial intelligence (AI), there has been a growing interest...